Monocytes in Retinal Degeneration: Little Cells with a Big Impact

Kaitryn E Ronning1, Marie E Burns2,3,4, Florian Sennlaub5

  • 1Sorbonne Université, CNRS, Inserm, Institut de la Vision, Paris, France. kaitryn.ronning@inserm.fr.

Insights

Inflammation drives retinal degenerative disorders. Monocyte-derived cells, distinct from microglia, play a key role and represent a promising therapeutic target for conditions like inherited retinal degenerations and age-related macular degeneration.

Area of Science:

  • Ophthalmology
  • Immunology
  • Neuroscience

Background:

  • Inflammation is a key factor in retinal degenerative disorders such as inherited retinal degenerations (IRDs) and age-related macular degeneration (AMD).
  • Microglia are the resident immune cells of the retina, but monocytes can infiltrate the retina during disease states.
  • Monocyte-derived cells (MdCs) may have distinct, potentially pathogenic roles compared to microglia.

Purpose of the Study:

  • To investigate the role of monocytic cells in retinal degenerative disorders.
  • To highlight the importance of monocytes as a potential therapeutic target.

Main Methods:

  • Utilizing recent technological advancements to study monocytic cells in the retina.
  • Comparative analysis of microglia and monocyte-derived cells.

Main Results:

  • Monocytes invade the retina during damage and disease.
  • Monocyte-derived cells exhibit distinct characteristics and functions compared to microglia.
  • Monocytes play a significant role in the pathogenesis of retinal degenerative disorders.

Conclusions:

  • Monocytes are crucial players in retinal degenerative diseases.
  • Monocyte-derived cells represent a promising target for developing novel therapeutic strategies for IRDs and AMD.